Daptomycin recalls
Daptomycin products have been recalled 3 times, most recently on 8 Mar 2023. The recalling company is usually Accord Healthcare. The most common reason is manufacturing (cgmp) deviations.
Total recalls3since 2020
Last 12 months0reported
Class I133% of total
Ongoing0latest 8 Mar 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 33%Class II 2 67%Class III 0 0%
Why daptomycin is recalled
Companies
Product types
By year
All daptomycin recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Daptomycin for Injection 350 mg/vial recalled by Accord HealthcareDaptomycin | Accord Healthcare | Manufacturing (CGMP) Deviations | PR |
| Drug | CLASS II | Daptomycin for Injection 500 mg per vial, Single-dose vial recalledDaptomycin | Accord Healthcare | Manufacturing (CGMP) Deviations | PR |
| Drug | CLASS I | Daptomycin for Injection, 500 mg/vial, Single-Dose Vial recalledDaptomycin | Mylan Institutional | Particulate Matter | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.